Harry Yiu

Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

Anthony T.�C. Chan, P. Teo, Roger K.C. Ngan et al. · Journal of Clinical Oncology · 2002 · 482 citations

Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy

George Lau, Harry Yiu, Hoi-Ching Cheng et al. · Gastroenterology · 2003 · 459 citations · Full text

Preemptive Lamivudine Therapy, Viral Hepatitis, Hepatitis B Patients +7

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study

Roger K.C. Ngan, Harry Yiu, W.H. Lau et al. · Annals of Oncology · 2002 · 176 citations · Full text

Surgical Oncology, Medicine, Metronomic Therapy +6

Preliminary results of trial NPC‐0501 evaluating the therapeutic gain by changing from concurrent‐adjuvant to induction‐concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma

Anne W.M. Lee, Roger K.C. Ngan, Stewart Y. Tung et al. · Cancer · 2014 · 167 citations

Autologous Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T Cell Lymphoma: A Multinational, Multicenter, Matched Controlled Study

Jeeyun Lee, Wing-Yan Au, Min Jae Park et al. · Biology of Blood and Marrow Transplantation · 2008 · 135 citations

Lymphoid Neoplasia, Cell Therapy, Transplantation +11